The lymphatic system of the uterine cervix: towards a more precise definition of the drainage routes.

doi:10.21203/rs.3.rs-1986964/v1

Download PDF

Research Article

The lymphatic system of the uterine cervix: towards a more precise definition of the drainage routes.

https://doi.org/10.21203/rs.3.rs-1986964/v1

This work is licensed under a CC BY 4.0 License

Version 1

posted

You are reading this latest preprint version

PURPOSE

Lymph node involvement in cervical cancer is a major independent prognostic factor for overall survival. The aim of our study was to examine the lymphatic drainage regions of the different parts of the cervix by an anatomical and radio-anatomical study.

METHODS

An anatomical study of fresh cadavers was conducted by injecting patent blue in the anterior or posterior cervical lip. Drainage regions were thereby compared according to the injection sites.

In parallel, a retrospective radiological and pathological study was conducted on patients who were treated for early-stage cervical cancer with lymph node involvement. Radiological analysis of pre-therapeutic MRIs and/or pathological analysis of surgical specimens showed the precise location of the tumour. A correlation between the anatomy of the primary lesion site and its lymphatic drainage was established.

RESULTS

We administered 8 cadaveric injections in the anterior cervical margin and 7 in the posterior cervical margin. For 100% of the anterior lip injections, lymphatic drainage was bilateral ileo-obturator (n=8/8) combined with bilateral parametrial drainage. For the posterior injections, there was never any ileo-obturator drainage, and 6 of the 7 (75%) posterior injections drained in the posterior uterine serosa. Among the 21 patients included, the radiological and pathological examination showed a non-significant tendency towards bilateral lymph node involvement when the tumour was located on the anterior cervical margin.

CONCLUSION

Through our study we were able to realize that the drainage of the cervix is not the same depending on the anterior or posterior location. This could have a major clinical interest in cervical cancer surgery.

Anatomy

cervix

Lymph node pathway

Sentinel lymph node

Uterus

Metastasis

Lymph node (LN) involvement still remains the most important prognostic factor for women with cervical cancer [1, 2]. However, because early-stage disease has a low risk of LN metastasis, over the past few decades, sentinel lymph node (SLN) mapping has received increased attention. This is a technique that could reduce the morbidity associated with ineffective lymphadenectomy [3]. Development of the SLN technique is relatively recent considering that use of the SLN was first described in 1977 by Dr Cabanas who performed lymphangiography to determine the node(s) to be removed in penile cancer surgery [4]. Somewhat later on, in the 1990s, the SLN technique became widely developed in breast cancer [5]. Doctors only became interested in this technique to treat endometrial and cervical cancers 10 years later, with the intention of de-escalating therapy to reduce surgical morbidity.

Since Ballester et al. published their preliminary SLN mapping experiment of cervical injection in women with endometrial cancer, much valuable literature has been produced. There are data supporting the usefulness in detecting micrometastases through the ultrastaging technique, which provides a lower complication rate than radical pelvic and/or aortic lymphadenectomy [6, 7].

In their first study, SENTICOL 1, in 2011, Lécuru et al. demonstrated the feasibility and sensitivity of sentinel node detection in cervical cancer [8]. A trial is currently in progress to determine the oncological safety and improvement in morbidity this procedure provides versus the reference treatment (bilateral ileo-obturator lymphadenectomy) in cervical cancer [9]. Through this work, we could gain insight into cervical lymphatic drainage as a whole, since cervical injection of isotopic and/or colorimetric products could then be used to locate the SLN, i.e. the first lymphatic connections. Few authors have studied cervical lymphatic drainage from an anatomical point of view, studying more specifically the pathways assigned to each part of the cervix. Several injection techniques are described in the literature with regard to the detection of the sentinel lymph node: some authors perform 2 injections in the 9 o'clock and 3 o'clock quadrants and others inject in the 4 quadrants of the cervix: at 12 o'clock, 3 o'clock, 6 o'clock and 9 o'clock. No study to date has highlighted the lymphatic drainage of the cervix according to these different anatomical regions: anterior or posterior border. In the area of conservative and minimally invasive management, it is legitimate to better characterize the anatomical lymphatic drainage of the cervix.

The aim of this work was to identify a physiological specificity of the lymphatic drainage region related to the different parts of the cervix.

Firstly, an anatomical study on fresh cadavers was conducted as follows: the non-injected bodies were warmed up beforehand by leaving them in ambient air for a minimum of 24 hours, or by an internal abdominopelvic bath with warm water. With the aid of a speculum, an injection of 2 ml of patent blue was then administered in the anterior (at noon) or posterior (a at 6 o'clock) cervical lip, under pressure. A midline laparotomy was then performed at least 6 hours after the injection, as this is the minimum time required to obtain lymphatic migration according to previous anatomical work (unpublished data). Drainage regions were then identified by inspection and dissection of the drainage areas (Fig. 1) These areas were inspected from proximal to distal: First, the anterior and posterior uterine serosa and the “parametrium” (regions located laterocervically). Then we dissected the “ilio-obturator areas” defined according to the surgical anatomy recalled by Cibula [10] as the external iliac and obturator areas, between the external iliac axis laterally, the umbilical artery medially, the common iliac artery bifurcation cranially, and the obturator nerve distally. The “common iliac regions” (lateral and ventral to the common iliac vessels) and then the “lumbo-aortic regions” (presacral, latero-aortic, preaortic, laterocaval, precaval, and inter-aortic-caval) are then examined. Finally, we reviewed the less classical drainage routes, in particular via the utero-sacral ligaments and the infundibulopelvic ligaments.

In parallel, a retrospective radiological and pathological study was carried out using a database from a previous study [2]. In brief, the retrospectively selected patients had presented with early stage cervical cancer, i.e. stage IA1, IA2, IB1, IB2 or IIA1 in the 2018 FIGO classification, without extension to the parametrium or neighbouring organs outside the upper 2/3 of the vagina, and for which surgery was performed at the Toulouse and Claudius Régaud University Hospital sites. Surgery consisted of a local procedure (conization, trachelectomy, hysterectomy) and staging by bilateral ilioobturator lymphadenectomy. In our study, the patients who were selected all had lymph node involvement. The precise location of the tumour was determined by MRI analysis, clinical examination data, or information from the pathology report. An analysis of the pathology report of the lymphadenectomies also allowed us to establish the location of the affected lymph node(s). Therefore, a correlation between the anatomy of the primary lesion site and its lymphatic drainage site was established for each patient (Fig. 2).

For the anatomical study, we had 15 fresh bodies of subjects aged 66 to 88 years at the time of death. In 7 cases (4 bodies injected in the anterior margin, 3 bodies in the posterior margin), the bodies had been taken out at room temperature less than 6 hours prior to the injection. An internal rewarming technique was then used: after median laparotomy an intra-abdominal bath was administered with water at approximately 37 to 40°C. The other bodies were taken out at room temperature 12 to 24 hours before use. With the aid of a speculum, a 2 ml submucosal injection of patent blue was administered in the anterior cervical margin in 8 cases, and in the posterior cervical margin in 7 cases. After an average waiting period of 15 hours (range: 6–24), we identified drainage regions by inspection and anatomical dissection.

In the majority of cases, there was bilateral parametrial drainage (10/15, including 4/8 for anterior injections and 6/7 for posterior injections), and at least unilateral ileo-obturator drainage (10/15, including 8/8 for anterior injections, and 2/7 for posterior injections).

In cases where the injection was administered in the anterior cervical margin (n = 8), there was therefore bilateral ileo-obturator drainage in 100% of the cases (8/8). Drainage in the anterior uterine serosa was noted in 87.5% of the cases (7/8), and never in the posterior uterine serosa. In 1 case (12.5%) there was ileo-obturator as well as bilateral common iliac and left infundibulopelvic ligament drainage. In another case there was a drainage pathway in the right parametrium, and on the left side deep in the uterosacral ligament. Finally, a drainage pathway in the 2 parametria, the 2 ileo-obturator areas as well as the anterior uterine serosa and the 2 infundibulopelvic ligaments demonstrated drainage that is more atypical.

If the injection was administered in the posterior cervical margin (n = 7), there was drainage in the parametrium and posterior uterine serosa in 85.7% of the cases (6/7). In 1 case (14.2%), no drainage beyond the parametrium was noted. In 2 cases (28.5%) there was unilateral ileo-obturator drainage. Finally, in 3 cases (42.8%) there was bilateral drainage through the uterosacral ligaments.

For the clinical study, the records of 20 patients managed for a small cervical cancer less than 4 cm in size and with lymph node involvement were analysed. Whether the tumour location was on the posterior anterior margin, lateralised or circumferential was determined according to the clinical examination, MRI and/or pathology report. The tumour was located on the anterior cervical margin in 6 cases (30%), the posterior margin in 7 cases (35%), and lateral or circumferential in 7 cases (35%). Only ilio-obturator lymphadenectomy was performed for this indication, in accordance with the recommendations. Ilio-obturator lymph node involvement was noted bilaterally in 60% of the cases of anterior tumours (4/6), and only unilaterally in 86% of the cases (6/7) of posterior cervical tumours. For circumferential or lateralised tumours (n = 7), ileo-obturator drainage was also predominantly unilateral (5/7, 71%).

Only few studies have been conducted on lymphatic cervical drainage. Indeed there is little data, which is sometimes contradictory, and above all variable, depending on the subjects studied, the injection technique used and probably the way in which the drainage pathways concerned are sought. Yet this knowledge of drainage is of major clinical interest. In fact, targeted removal of lymph nodes in a specific drainage region reduces the morbidity of surgical procedures, in particular the risk of lymphoedema (Achouri et al., 2013; Biglia et al., 2015). Likewise, considering that pelvic lymphadenectomy generates several complications, the sentinel lymph node (SLN) technique has been introduced for 20 years and is increasingly used in cervical cancer. One of the interests of SLN is to highlight the aberrant drainage territories that are not systematically dissected during routine lymphadenectomies [11]. It therefore seemed important to us to better characterize the lymphatic drainage according to the anatomical regions of the cervix to better apprehend the aberrant drainages. Our results show that drainage is mainly in the iliac areas, but through our anatomical examination, we were also able to demonstrate more atypical drainage, in particular in the uterine serosa, the infundibulopelvic ligaments, the uterosacral ligaments and the common iliac region. However, we visualised no para-aortic drainage. Our work has also provided additional information to refine our knowledge of cervical lymphatic drainage. In our anatomical work we observed so-called "classic" drainage systematically for injections in the anterior cervical lip at the ileo-obturator connection, sometimes associated with more atypical drainages (common iliac, uterine serosa or infundibulopelvic ligament). Drainage of the posterior cervical lip appeared to be less conventional, with much less systematic drainage via the ileo-obturator lymph nodes, but rather via the uterosacral ligaments and the posterior uterine serosa.

Rouvière [12] gave a definition which is often used as a reference in books on surgical techniques. Cervical drainage is schematised in 2 regions: the external and the internal iliac. In 1997, Lécuru et al. conducted a preliminary anatomical study for the SENTICOL trials [13]. For this they injected the cervices of 6 bodies. Despite the fact that there were few patients in this study, they were able to observe a vast majority of the drainages under the external iliac veins (40%) and at the roots of the internal iliac veins (60%), which is in keeping with the work by Rouvière. This definition has the advantage of being simple but is probably too simplistic, as we shall see later, and we can already note that among the bodies injected by Lecuru, drainage in the infundibulopelvic pathway occurred in 20% of the cases [13].

The SENTICOL trials subsequently provided very interesting data on cervical lymphatic drainage. Therefore, in 2020, Balaya et al. took back the patients in the SENTICOL 1 and 2 trials who were managed for early cervical cancers without preoperative suspicion of lymph node involvement, with identification of SLNs to determine the risk factors of failure of the technique [14]. Most of the sentinel nodes were located in the ileo-obturator and external iliac zone (n = 977, or 82.6%), followed by the common iliac region (n = 109, i.e., 9.2%). Drainages were also described from the Senticol 1 and 2 patients [15]: 3.9% of the drainage regions were in the parametrium, 1.6% in the promontory, 1.5% in the para-aortic area, and 0.5% in other areas. Senticol 3 is currently in the inclusion phase to validate the effect of SLN alone without lymphadenectomy on recurrence-free survival and quality of life. Other studies have confirmed these so-called "atypical" drainages, outside the iliac areas. In 2004, Altgassen et al reported a certain proportion of para-aortic SLN [16] and in 2006, Marnitz et al, for the AGO (Association of Gynaecological Oncologist), found para-aortic drainage in 4% of the cases, common iliac drainage in 5%, external iliac in 5%, internal iliac in 8%, and parametrial in 7% [17]. They also observed that more para-aortic SLN were found in the event of joint injection of patent blue and a radioactive tracer, which shows the potential variability of results linked to the technique used.

It is of note that finally, few studies have been conducted on lymphatic cervical drainage. There is little data, which is sometimes contradictory, and above all variable, depending on the subjects studied, the injection technique used and probably the way in which the drainage pathways concerned are sought.

Yet this knowledge of drainage is of major clinical interest. In fact, targeted removal of lymph nodes in a specific drainage region reduces the morbidity of surgical procedures, in particular the risk of lymphoedema [18, 19]

At present, sentinel node detection in cervical cancer is still in the experimental stage to prove oncological safety, as the resulting reduction in morbidity no longer needs to be proven. It is classically done by double detection of migration after injection in the cervix, using a colorimetric method (patent blue), and radioisotope (technetium 99m). Although this dual detection has resulted in a better detection rate of sentinel nodes, there are still failures of migration and/or detection. In 2020, Balaya et al reported a detection rate that was at least unilateral in 94.1% of the cases, and bilateral in 80.4% of the 405 patients included in the analysis [14]. Similarly, in their study of 245 patients, Sponholtz et al reported a unilateral detection rate of 96.3% and a bilateral detection rate of 82% [20].

One technique that is being developed uses indocyanine green fluorescence. In a meta-analysis published in 2016, Ruscito et al revealed that in cervical cancer, this method showed a better detection rate than patent blue used alone, and a detection rate equivalent to the combination of blue and technetium[21]. However, these immunofluorescence and radio-guided detection techniques require structural equipment that is not always available in developing countries, and are expensive, to the patient’s detriment, in regions where the incidence of cervical cancer is highest [22]. The importance of being able to target lymphadenectomy regions according to the location of the cervical cancer could therefore avoid some morbidity by optimising the surgical management of cancer in centres where the SLN technique could not be implemented.

The contribution of PET scans in lymph node staging of cervical cancer remains to be demonstrated. In fact, given the lack of therapeutic value of lymphadenectomy, which is only of interest for predicting the extent of radiotherapy fields, an alternative, non-invasive examination is needed. A review of the literature from 2020 examines the performances of PET scans in predicting lymph node involvement in locally advanced cervical cancer [23]. It appears that the positive and negative predictive values improve when the examination is performed in a population with a higher prevalence of lymph node involvement, i.e. in large volume and/or locally advanced cancers. Therefore, in these populations PET scans are important and, although their exclusive use is not recommended at present, could allow surgery to be avoided. However, in small cancers the performance of FDG PET is less clear. In the Sponholtz study, 103 patients with a median cancer size of 28.0 mm (range 21.0–63.0), the sensitivity of FDG PET/CT alone was 14.8% (95% CI 4.2–33.7%), and the specificity, 85.5% (95% CI 75.6–92.5%) [20]. Therefore, it is difficult to bypass surgical lymph node staging, especially in small cervical cancers.

The limitations of our work are mainly due to the number of cases presented, which is partly due to the difficulties associated with cadaveric studies, and partly due to the small number of patients with early-stage cervical cancer (for whom the precise location of the tumour is therefore possible), and associated lymph node involvement (which makes it possible to identify the tumour drainage site). In the clinical part of our study, the limitation of the information collected is also related to the fact that only pelvic lymphadenectomies were performed, and consequently, more atypical drainage areas may have been overlooked. Hence, once again, there is a clinical interest for the SLN in the complete mapping of drainage regions during oncological treatment of cervical cancer.

Likewise, the lymphatic circulation in the corpse is difficult to reproduce which surely explains the absence of drainage highlighted in the para-aortic nodes. Nevertheless, this is a preliminary study, the results of which encourage further work with a module allowing fluids to recirculate.

Better knowledge of cervical lymphatic drainage is necessary in order to be able to propose "individualised" surgical treatment to patients with cervical cancer, without ignoring more atypical drainage regions according to the precise location of the tumour. Our study has provided a more detailed knowledge of the cervical drainage regions, based on an anatomical analysis of the pelvis. However, further studies are needed, and the perfused re-ventilated cadaver model (SIMLIFE model) could contribute considerably to the examination of the lymphatic system, which is fragile and difficult to study as shown by the extremely variable results of previous work.

ACKNOWLEDGMENTS

The authors sincerely thank those who donated their bodies to science so that anatomical research could be performed. Results from such research can potentially increase mankind's overall knowledge that can then improve patient care. Therefore, these donors and their families deserve our highest gratitude.

Ethical Approval

All patients of the clinical study signed a written consent to participate. All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.

Competing interests

None of the authors declare any conflict of interest.

Authors' contributions

Ariane Weyl : Manuscript writing, Data collection, Data analysis

Claire Sanson : Data collection

Matthieu Roumiguié : Project development

Patrick Chaynes : Technical support

Jacques Rimailho : Project development

Alejandra Martinez : Manuscript editing

Elodie Chantalat : Project development, Manuscript editing

Funding

No funding was used for this project.

Availability of data and materials

Data are available on request.

Ho C-M, Chien T-Y, Huang S-H, Wu C-J, Shih B-Y, Chang S-C (2004) Multivariate analysis of the prognostic factors and outcomes in early cervical cancer patients undergoing radical hysterectomy. Gynecol Oncol 93:458–464. https://doi.org/10.1016/j.ygyno.2004.01.026
Weyl A, Illac C, Lusque A, Leray H, Vaysse C, Martinez A, Chantalat E, Motton S (2020) Prognostic value of lymphovascular space invasion in early-stage cervical cancer. Int J Gynecol Cancer 30:1493–1499. https://doi.org/10.1136/ijgc-2020-001274
Granzow JW, Soderberg JM, Kaji AH, Dauphine C (2014) Review of current surgical treatments for lymphedema. Ann Surg Oncol 21:1195–1201. https://doi.org/10.1245/s10434-014-3518-8
Cabanas RM (1977) An approach for the treatment of penile carcinoma. Cancer 39:456–466. https://doi.org/10.1002/1097-0142(197702)39:2<456::aid-cncr2820390214>3.0.co;2-i
Giuliano AE, Kirgan DM, Guenther JM, Morton DL (1994) Lymphatic mapping and sentinel lymphadenectomy for breast cancer. Ann Surg 220:391–398; discussion 398–401. https://doi.org/10.1097/00000658-199409000-00015
Ballester M, Dubernard G, Rouzier R, Barranger E, Darai E (2008) Use of the sentinel node procedure to stage endometrial cancer. Ann Surg Oncol 15:1523–1529. https://doi.org/10.1245/s10434-008-9841-1
Leitao MM, Khoury-Collado F, Gardner G, Sonoda Y, Brown CL, Alektiar KM, Hensley ML, Soslow RA, Barakat RR, Abu-Rustum NR (2013) Impact of incorporating an algorithm that utilizes sentinel lymph node mapping during minimally invasive procedures on the detection of stage IIIC endometrial cancer. Gynecol Oncol 129:38–41. https://doi.org/10.1016/j.ygyno.2013.01.002
Lécuru F, Mathevet P, Querleu D, Leblanc E, Morice P, Daraï E, Marret H, Magaud L, Gillaizeau F, Chatellier G, Dargent D (2011) Bilateral negative sentinel nodes accurately predict absence of lymph node metastasis in early cervical cancer: results of the SENTICOL study. J Clin Oncol 29:1686–1691. https://doi.org/10.1200/JCO.2010.32.0432
Lecuru FR, McCormack M, Hillemanns P, Anota A, Leitao M, Mathevet P, Zweemer R, Fujiwara K, Zanagnolo V, Zahl Eriksson AG, Hudson E, Ferron G, Plante M (2019) SENTICOL III: an international validation study of sentinel node biopsy in early cervical cancer. A GINECO, ENGOT, GCIG and multicenter study. Int J Gynecol Cancer 29:829–834. https://doi.org/10.1136/ijgc-2019-000332
Cibula D, Abu-Rustum NR (2010) Pelvic lymphadenectomy in cervical cancer—surgical anatomy and proposal for a new classification system. Gynecologic Oncology 116:33–37. https://doi.org/10.1016/j.ygyno.2009.09.003
Bats A-S, Mathevet P, Buenerd A, Orliaguet I, Mery E, Zerdoud S, Le Frère-Belda M-A, Froissart M, Querleu D, Martinez A, Leblanc E, Morice P, Daraï E, Marret H, Gillaizeau F, Lécuru F (2013) The sentinel node technique detects unexpected drainage pathways and allows nodal ultrastaging in early cervical cancer: insights from the multicenter prospective SENTICOL study. Ann Surg Oncol 20:413–422. https://doi.org/10.1245/s10434-012-2597-7
Rouvière (1875–1952) H (1932) Anatomie des lymphatiques de l’homme
Lécuru F, Neji K, Robin F, Darles C, de Bièvre P, Taurelle R (1997) [Lymphatic drainage of the uterus. Preliminary results of an experimental study]. J Gynecol Obstet Biol Reprod (Paris) 26:418–423
Balaya V, Bresset A, Guani B, Magaud L, Montero Macias R, Delomenie M, Bonsang-Kitzis H, Ngô C, Bats AS, Mathevet P, Lécuru F (2020) Risk factors for failure of bilateral sentinel lymph node mapping in early-stage cervical cancer. Gynecol Oncol 156:93–99. https://doi.org/10.1016/j.ygyno.2019.10.027
Balaya V, Mathevet P, Magaud L, Bonsang-Kitzis H, Delomenie M, Montero Macias R, Ngô C, Bats AS, Lécuru F (2019) Predictive factors of unexpected lymphatic drainage pathways in early-stage cervical cancer. Gynecol Oncol 154:102–109. https://doi.org/10.1016/j.ygyno.2019.04.008
Altgassen C, Hertel H, Brandstädt A, Köhler C, Dürst M, Schneider A, AGO Study Group (2008) Multicenter validation study of the sentinel lymph node concept in cervical cancer: AGO Study Group. J Clin Oncol 26:2943–2951. https://doi.org/10.1200/JCO.2007.13.8933
Marnitz S, Köhler C, Bongardt S, Braig U, Hertel H, Schneider A, German Association of Gynecologic Oncologists (AGO) (2006) Topographic distribution of sentinel lymph nodes in patients with cervical cancer. Gynecol Oncol 103:35–44. https://doi.org/10.1016/j.ygyno.2006.01.061
Biglia N, Librino A, Ottino MC, Panuccio E, Daniele A, Chahin A (2015) Lower limb lymphedema and neurological complications after lymphadenectomy for gynecological cancer. Int J Gynecol Cancer 25:521–525. https://doi.org/10.1097/IGC.0000000000000341
Achouri A, Huchon C, Bats AS, Bensaid C, Nos C, Lécuru F (2013) Complications of lymphadenectomy for gynecologic cancer. Eur J Surg Oncol 39:81–86. https://doi.org/10.1016/j.ejso.2012.10.011
Sponholtz SE, Mogensen O, Hildebrandt MG, Schledermann D, Parner E, Markauskas A, Frøding LP, Fuglsang K, Vilstrup MH, Bjørnholt SM, Jensen PT (2021) Sentinel lymph node mapping in early-stage cervical cancer - A national prospective multicenter study (SENTIREC trial). Gynecol Oncol S0090-8258(21)00512–6. https://doi.org/10.1016/j.ygyno.2021.06.018
Ruscito I, Gasparri ML, Braicu EI, Bellati F, Raio L, Sehouli J, Mueller MD, Panici PB, Papadia A (2016) Sentinel Node Mapping in Cervical and Endometrial Cancer: Indocyanine Green Versus Other Conventional Dyes—A Meta-Analysis. Ann Surg Oncol 23:3749–3756. https://doi.org/10.1245/s10434-016-5236-x
GLOBOCAN Cancer Fact Sheets: Cervical cancer. http://globocan.iarc.fr/old/FactSheets/cancers/cervix-new.asp. Accessed 7 Apr 2018
Adam JA, van Diepen PR, Mom CH, Stoker J, van Eck-Smit BLF, Bipat S (2020) [18F]FDG-PET or PET/CT in the evaluation of pelvic and para-aortic lymph nodes in patients with locally advanced cervical cancer: A systematic review of the literature. Gynecol Oncol 159:588–596. https://doi.org/10.1016/j.ygyno.2020.08.021

No competing interests reported.

Download PDF

Version 1

posted

You are reading this latest preprint version

The lymphatic system of the uterine cervix: towards a more precise definition of the drainage routes.

Status:

Version 1

Abstract

Figures

Introduction

Materials And Methods

Results

Discussion

Conclusion

Declarations

ACKNOWLEDGMENTS

References

Additional Declarations

Status:

Version 1